Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Exelon Corporation (EXC) A Good Stock To Buy?

Is Exelon Corporation (NYSE:EXC) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get tips from investment bankers and industry insiders. Sure they sometimes fail miserably but historically their consensus stock picks outperformed the market after adjusting for known risk factors.

Exelon Corporation (NYSE:EXC) shares haven’t seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 33 hedge funds’ portfolios at the end of the fourth quarter of 2018. At the end of this article we will also compare EXC to other stocks including Orange (NYSE:ORAN), Intercontinental Exchange Inc (NYSE:ICE), and HCA Healthcare Inc (NYSE:HCA) to get a better sense of its popularity.

In the financial world there are a large number of tools investors have at their disposal to grade stocks. A pair of the most under-the-radar tools are hedge fund and insider trading indicators. We have shown that, historically, those who follow the top picks of the best fund managers can outperform the broader indices by a solid amount. Insider Monkey’s flagship best performing hedge funds strategy returned 20.7% year to date (through March 12th) and outperformed the market even though it draws its stock picks among small-cap stocks. This strategy also outperformed the market by 32 percentage points since its inception (see the details here). That’s why we believe hedge fund sentiment is a useful indicator that investors should pay attention to.

Dmitry Balyasny

Let’s take a gander at the new hedge fund action surrounding Exelon Corporation (NYSE:EXC).

How have hedgies been trading Exelon Corporation (NYSE:EXC)?

Heading into the first quarter of 2019, a total of 33 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 0% from one quarter earlier. By comparison, 28 hedge funds held shares or bullish call options in EXC a year ago. So, let’s find out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

EXC_mar2019

More specifically, AQR Capital Management was the largest shareholder of Exelon Corporation (NYSE:EXC), with a stake worth $801.5 million reported as of the end of September. Trailing AQR Capital Management was GLG Partners, which amassed a stake valued at $269.4 million. Renaissance Technologies, Balyasny Asset Management, and Citadel Investment Group were also very fond of the stock, giving the stock large weights in their portfolios.

Seeing as Exelon Corporation (NYSE:EXC) has witnessed falling interest from the aggregate hedge fund industry, logic holds that there exists a select few fund managers that slashed their positions entirely heading into Q3. Intriguingly, Stuart J. Zimmer’s Zimmer Partners cut the biggest investment of the 700 funds watched by Insider Monkey, comprising about $69.5 million in stock. Bernard Lambilliotte’s fund, Ecofin Ltd, also dropped its stock, about $17.9 million worth. These bearish behaviors are intriguing to say the least, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

Let’s now take a look at hedge fund activity in other stocks – not necessarily in the same industry as Exelon Corporation (NYSE:EXC) but similarly valued. We will take a look at Orange S.A. (NYSE:ORAN), Intercontinental Exchange Inc (NYSE:ICE), HCA Healthcare Inc (NYSE:HCA), and S&P Global Inc. (NYSE:SPGI). This group of stocks’ market caps are similar to EXC’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
ORAN 2 398 1
ICE 41 2692581 5
HCA 56 2707875 10
SPGI 54 2920608 0
Average 38.25 2080366 4

View table here if you experience formatting issues.

As you can see these stocks had an average of 38.25 hedge funds with bullish positions and the average amount invested in these stocks was $2080 million. That figure was $2059 million in EXC’s case. HCA Healthcare Inc (NYSE:HCA) is the most popular stock in this table. On the other hand Orange S.A. (NYSE:ORAN) is the least popular one with only 2 bullish hedge fund positions. Exelon Corporation (NYSE:EXC) is not the least popular stock in this group but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. Our calculations showed that top 15 most popular stocks among hedge funds returned 19.7% through March 15th and outperformed the S&P 500 ETF (SPY) by 6.6 percentage points. Unfortunately EXC wasn’t in this group. Hedge funds that bet on EXC were disappointed as the stock returned 11.7% and underperformed the market. If you are interested in investing in large cap stocks, you should check out the top 15 hedge fund stocks as 13 of these outperformed the market.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...